Cagrilintide – Amylin Receptor Agonist | 5mg
Cagrilintide – Amylin Receptor Agonist | 5mg Lyophilized Powder | RUO Grade | BlueBiotech® Research Supply
Long-Acting Metabolic Peptide for Appetite Suppression and Energy Balance Studies | Made in USA | Research Use Only
Cagrilintide is a long-acting amylin receptor agonist designed to mimic the effects of endogenous amylin in regulating appetite, satiety, and energy balance. It is being studied in combination with GLP-1 analogs for enhanced weight reduction in obesity models. Supplied as RUO-grade 5mg lyophilized powder. For Research Use Only – Not for human or veterinary use.
| Field Name | Example Value |
|---|---|
| Product Name | Cagrilintide – Amylin Receptor Agonist | 5mg Lyophilized Powder | RUO Grade | BlueBiotech® Research Supply |
| Product Code | BBT-US-30-699798 |
| Product Type | Research Peptide |
| Category | Peptides / Weight Management / Appetite Modulation / Amylin Analog |
| Manufacturer | BlueBiotech® Research Facility |
| Appearance | White lyophilized powder |
| Dosage / Units | 5mg per vial |
| Purity | ≥99% (HPLC) |
| Quantity Options | 2mg / 5mg |
| Storage | Store at -20°C; protect from light and moisture |
| Shelf Life | 24 months unopened |
| Packaging | RUO-labeled sterile 10R vial, sealed foil pouch |
| Manufacturer Origin | USA – Made in USA |
| Use Classification | RUO – Research Use Only (Not intended for human or veterinary use) |
| Tags | Cagrilintide, amylin analog, weight loss peptide, metabolic hormone, appetite regulation, BlueBiotech, RUO, 5mg, made in USA, energy balance research |
⚠️This product is labeled for Research Use Only (RUO). Not for human or veterinary therapeutic use.
See RUO Declaration for more info.
Cagrilintide – Amylin Receptor Agonist | 5mg | RUO Grade | BlueBiotech®
Product Overview
Cagrilintide is a long-acting amylin receptor agonist, structurally modified from the native amylin peptide to improve pharmacokinetics, receptor affinity, and resistance to enzymatic degradation. It is being investigated for its role in regulating satiety, gastric emptying, and energy balance, particularly in the context of obesity, type 2 diabetes, and combination incretin therapies.
Cagrilintide mimics the physiological effects of human amylin, a hormone co-secreted with insulin by pancreatic β-cells. Its synergistic effects with GLP-1 receptor agonists, such as semaglutide, have made it a focus of recent multi-target weight management strategies.
This compound is manufactured by BlueBiotech® in the USA and supplied as a 5mg RUO-grade lyophilized powder with ≥99% purity, suitable for scientific investigations only.
🔬 Learn More:
Key Features
-
✅ Synthetic analog of human amylin with extended half-life
-
✅ Potent amylin receptor agonist activity
-
✅ ≥99% purity (HPLC confirmed)
-
✅ Supplied as 5mg lyophilized peptide per vial
-
✅ Manufactured in the USA by BlueBiotech®
-
✅ Research Use Only – Not for clinical or therapeutic applications
Specifications
-
Compound Name: Cagrilintide
-
CAS Number: N/A (Investigational peptide)
-
Molecular Formula: Peptide-based (proprietary structure)
-
Molecular Weight: Approx. 4–5 kDa
-
Purity: ≥99% (HPLC)
-
Form: White/off-white lyophilized powder
-
Solubility: Sterile water, acetic acid
-
Content: 5mg per vial
-
Storage: –20°C; protect from light and moisture
-
Shelf Life: 24 months unopened
-
Classification: RUO (Research Use Only)
Research Applications
-
Studies on satiety signaling and appetite suppression
-
Evaluation of gastric motility modulation
-
Exploration of amylin receptor pharmacodynamics
-
Preclinical models of obesity, insulin resistance, and postprandial glucose control
-
Combination studies with GLP-1 analogs like semaglutide or tirzepatide
⚠️ Compliance Statement
This product is designated For Research Use Only (RUO). It is not approved for human or animal use and must not be used for therapeutic, diagnostic, or clinical purposes. Researchers must comply with all local and institutional regulations.
Tags / Keywords
Cagrilintide RUO, Amylin Receptor Agonist, Appetite Regulation Peptide, Satiety Hormone Analog, BlueBiotech Metabolic Peptides, Weight Loss Research Tool, GLP-1 Synergy Peptide, RUO Obesity Compound
Also in GLP-1 Peptides:
Similar Products
![Saxenda® liraglutide injection [Korean Edition] 6mg/ml 3ml](https://www.bluebiotech.health/wp-content/uploads/2024/12/2-12-600x800.jpg)
![Tizaro® (Tirzepatide) Injection [Bangladesh]](https://www.bluebiotech.health/wp-content/uploads/2024/11/Tizaro-Tirzepatide-Injection-7.5-600x800.jpg)
![Tirzep®-Tirzepatide Injection [ACI - Bangladesh]](https://www.bluebiotech.health/wp-content/uploads/2024/11/Tirzep-Tirzepatide-Injection-7.5-600x800.jpg)
Corporate Advantages
High-Purity Standards
Tested for purity and identity. COAs available
for all RUO compounds
Buyer Protection
Protected and discrete fulfillment
available upon request
Research-Grade Support
Dedicated service for labs, clinics, and
compounders handling RUO items.
Lab-Grade Quality Assurance
All compounds are tested for-identity and purity, COAs and supporting documentation are available upon request.
Strict RUO Compliance
All products are labeled for Researd Use Only (RUO), Not intended for human or veterinary therapeutic or diagnostic purposes.
Lab-Grade Quality Assurance
Custom branding.
white-label optionons and formulation assistancee available for eligible research institutions and partners.
Custom R&D & APl Synthesis
We support original
pharmaceutica solutions.custom research projects, and NDC-grade materials-meeting speifica.tions for qualified partners.
Serving Professionals Across the U.S.& Mexico
Trusted by MedSpas, wellness clinics and licensed compounders under licensed compounding relationships.
Secure & Discreet Fulfillment
Cold-chain shipping : private, plain.wrap packaging, and tracking for sensitive RUO materials.
⚠️ All compounds are provided strictly for Research Use Only (RUO). BLUEBIOTECH does not endorse or support clinical, therapeutic, or diagnostic use of its products unless under licensed compounder supervision.